(Q54474048)

30 May 2018

title

Hemodynamic effects of vasodilators and long-term response in heart failure (English)

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80292-2

28 September 2023

0 references

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80292-2

28 September 2023

author name string

J. A. Franciosa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6325522

28 September 2023

W. B. Dunkman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6325522

28 September 2023

C. L. Leddy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6325522

28 September 2023

language of work or name

English

0 references

publication date

1 June 1984

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0735109784802922?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80292-2

https://api.elsevier.com/content/article/PII:S0735109784802922?httpAccept=text/plain

28 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80292-2

Journal of the American College of Cardiology

28 September 2023

published in

1 reference

30 May 2018

volume

3

1 reference

30 May 2018

issue

6

1 reference

30 May 2018

page(s)

1521-1530

1 reference

30 May 2018

Vasodilator therapy of cardiac failure: (first of two parts)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Exercise capacity in patients with severe left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Dose requirements of hydralazine in patients with severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Evaluation of the CO2 rebreathing cardiac output method in seriously ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

CONTINUOUS MEASUREMENT OF VENTILATORY EXCHANGE RATIO DURING EXERCISE

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Effects of minoxidil on hemodynamics in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Cardiovascular clinical pharmacology of impedance reducing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Long-term therapy of heart failure with prazosin: a randomized double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Results of long-term vasodilator therapy in patients with refractory congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Left ventricular function in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Treatment of refractory heart failure with infusion of nitroprusside.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

The natural history of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980292-2

7 January 2021

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018